| High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity ZA Rizvi, R Dalal, S Sadhu, Y Kumar, S Kumar, SK Gupta, MR Tripathy, ... Science Advances 7 (37), eabg5016, 2021 | 102 | 2021 |
| Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection ZA Rizvi, R Dalal, S Sadhu, A Binayke, J Dandotiya, Y Kumar, ... Elife 11, e73522, 2022 | 65 | 2022 |
| Effect of prophylactic use of intranasal oil formulations in the hamster model of COVID-19 ZA Rizvi, MR Tripathy, N Sharma, S Goswami, N Srikanth, JLN Sastry, ... Frontiers in Pharmacology 12, 746729, 2021 | 25 | 2021 |
| Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis ZA Rizvi, P Babele, S Sadhu, U Madan, MR Tripathy, S Goswami, S Mani, ... Frontiers in Immunology 13, 945583, 2022 | 23 | 2022 |
| Pharmacological potential of Withania somnifera (L.) Dunal and Tinospora cordifolia (Willd.) Miers on the experimental models of COVID-19, T cell differentiation … ZA Rizvi, P Babele, U Madan, S Sadhu, MR Tripathy, S Goswami, S Mani, ... Frontiers in Immunology 14, 1138215, 2023 | 18 | 2023 |
| IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation S Sadhu, R Dalal, J Dandotiya, A Binayke, V Singh, MR Tripathy, V Das, ... Nature Communications 14 (1), 4060, 2023 | 15 | 2023 |
| Proinflammatory innate cytokines and distinct metabolomic signatures shape the T cell response in active COVID-19 A Binayke, A Zaheer, J Dandotiya, SK Gupta, S Mani, MR Tripathy, ... Vaccines 10 (10), 1762, 2022 | 10 | 2022 |
| G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters SS Roy, S Sharma, ZA Rizvi, D Sinha, D Gupta, M Rophina, P Sehgal, ... Frontiers in Molecular Biosciences 10, 1133123, 2023 | 2 | 2023 |
| A broadly neutralising monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV2 variant of concerns R Kumar, H Parray, N Narayan, S Garg, ZA Rizvi, T Shrivastava, ... | 2 | 2022 |
| Anti-COVID-19 Activity of FDA Approved Drugs through RNA G-quadruplex Binding SS Roy, S Sharma, ZA Rizvi, D Sinha, D Gupta, M Rophina, P Sehgal, ... bioRxiv, 2022.05. 31.493843, 2022 | 1 | 2022 |
| Berbamine prevents SARS-CoV-2 entry and transmission S Sadhu, S Goswami, R Khatri, B Lohiya, V Singh, R Yadav, V Das, ... iScience, 2024 | | 2024 |
